1.
Greenwood SM, Moran JJ. Chronic endometritis: morphologic and clinical observations. Obstet Gynecol. 1981; 58(2):176–84. PMID: 7254729
2.
Kitaya K, Yasuo T. Immunohistochemistrical and clinicopathological characterization of chronic endometritis. Am J Reprod Immunol. 2011; 66(5):410–5. https://doi.org/10.1111/j.1600-0897.2011.01051.x
PMID: 21749546
3.
Crum CP, Egawa K, Fenoglio CM, Richart RM. Chronic endometritis: the role of immunohistochemistry
in the detection of plasma cells. Am J Obstet Gynecol. 1983; 147(7):812–5. https://doi.org/10.1016/
0002-9378(83)90045-5 PMID: 6359886
4.
Cicinelli E, Matteo M, Tinelli R, Lepera A, Alfonso R, Indraccolo U, et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum
Reprod. 2015; 30(2):323–30. https://doi.org/10.1093/humrep/deu292 PMID: 25385744
5.
Johnston-MacAnanny EB, Hartnett J, Engmann LL, Nulsen JC, Sanders MM, Benadiva CA. Chronic
endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization.
Fertil Steril. 2010; 93(2):437–41. https://doi.org/10.1016/j.fertnstert.2008.12.131 PMID: 19217098
6.
Polisseni F, Bambirra EA, Camargos AF. Detection of chronic endometritis by diagnostic hysteroscopy
in asymptomatic infertile patients. Gynecol Obstet Invest. 2003; 55(4):205–10. https://doi.org/10.1159/
000072075 PMID: 12904693
7.
Kaku S, Kubo T, Kimura F, Nakamura A, Kitazawa J, Morimune A, et al. Relationship of chronic endometritis with chronic deciduitis in cases of miscarriage. BMC Womens Health. 2020; 20(1):114. https://
doi.org/10.1186/s12905-020-00982-y PMID: 32487112
8.
Morimune A, Kimura F, Nakamura A, Kitazawa J, Takashima A, Amano T, et al. The effects of chronic
endometritis on the pregnancy outcomes. Am J Reprod Immunol. 2020:e13357. https://doi.org/10.
1111/aji.13357 PMID: 33020952
9.
Kimura F, Takebayashi A, Ishida M, Nakamura A, Kitazawa J, Morimune A, et al. Review: Chronic
endometritis and its effect on reproduction. J Obstet Gynaecol Res. 2019; 45(5):951–60. https://doi.org/
10.1111/jog.13937 PMID: 30843321
10.
Xu Y, Mei J, Diao L, Li Y, Ding L. Chronic endometritis and reproductive failure: Role of syndecan-1. Am
J Reprod Immunol. 2020:e13255. https://doi.org/10.1111/aji.13255 PMID: 32329146
11.
Bayer-Garner IB, Nickell JA, Korourian S. Routine syndecan-1 immunohistochemistry aids in the diagnosis of chronic endometritis. Arch Pathol Lab Med. 2004; 128(9):1000–3. https://doi.org/10.1043/
1543-2165(2004)128<1000:RSIAIT>2.0.CO;2 PMID: 15335255
12.
Li Y, Yu S, Huang C, Lian R, Chen C, Liu S, et al. Evaluation of peripheral and uterine immune status of
chronic endometritis in patients with recurrent reproductive failure. Fertil Steril. 2020; 113(1):187–96 e1.
https://doi.org/10.1016/j.fertnstert.2019.09.001 PMID: 31718829
13.
Wu D, Kimura F, Zheng L, Ishida M, Niwa Y, Hirata K, et al. Chronic endometritis modifies decidualization in human endometrial stromal cells. Reprod Biol Endocrinol. 2017; 15(1):16. https://doi.org/10.
1186/s12958-017-0233-x PMID: 28259137
14.
Kitazawa J, Kimura F, Nakamura A, Morimune A, Hanada T, Amano T, et al. Alteration in endometrial
helper T-cell subgroups in chronic endometritis. Am J Reprod Immunol. 2020:e13372. https://doi.org/
10.1111/aji.13372 PMID: 33155317
15.
Barriere G, Fici P, Gallerani G, Fabbri F, Rigaud M. Epithelial Mesenchymal Transition: a double-edged
sword. Clin Transl Med. 2015; 4:14. https://doi.org/10.1186/s40169-015-0055-4 PMID: 25932287
16.
Goossens S, Vandamme N, Van Vlierberghe P, Berx G. EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET. Biochim Biophys Acta Rev Cancer. 2017; 1868(2):584–91.
https://doi.org/10.1016/j.bbcan.2017.06.006 PMID: 28669750
PLOS ONE | https://doi.org/10.1371/journal.pone.0249775 April 7, 2021
11 / 14
PLOS ONE
EMT in CE endometrium
17.
Saitoh M. Involvement of partial EMT in cancer progression. J Biochem. 2018; 164(4):257–64. https://
doi.org/10.1093/jb/mvy047 PMID: 29726955
18.
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev
Mol Cell Biol. 2014; 15(3):178–96. https://doi.org/10.1038/nrm3758 PMID: 24556840
19.
Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal.
2014; 7(344):re8. https://doi.org/10.1126/scisignal.2005189 PMID: 25249658
20.
Paria BC, Zhao X, Das SK, Dey SK, Yoshinaga K. Zonula occludens-1 and E-cadherin are coordinately
expressed in the mouse uterus with the initiation of implantation and decidualization. Dev Biol. 1999;
208(2):488–501. https://doi.org/10.1006/dbio.1999.9206 PMID: 10191061
21.
Zhang XH, Liang X, Liang XH, Wang TS, Qi QR, Deng WB, et al. The mesenchymal-epithelial transition
during in vitro decidualization. Reprod Sci. 2013; 20(4):354–60. https://doi.org/10.1177/
1933719112472738 PMID: 23302397
22.
Gou J, Hu T, Li L, Xue L, Zhao X, Yi T, et al. Role of epithelial-mesenchymal transition regulated by twist
basic helix-loop-helix transcription factor 2 (Twist2) in embryo implantation in mice. Reprod Fertil Dev.
2019; 31(5):932–40. https://doi.org/10.1071/RD18314 PMID: 30779884
23.
Uchida H, Maruyama T, Nishikawa-Uchida S, Oda H, Miyazaki K, Yamasaki A, et al. Studies using an in
vitro model show evidence of involvement of epithelial-mesenchymal transition of human endometrial
epithelial cells in human embryo implantation. J Biol Chem. 2012; 287(7):4441–50. https://doi.org/10.
1074/jbc.M111.286138 PMID: 22174415
24.
Chi RA, Wang T, Adams N, Wu SP, Young SL, Spencer TE, et al. Human Endometrial Transcriptome
and Progesterone Receptor Cistrome Reveal Important Pathways and Epithelial Regulators. J Clin
Endocrinol Metab. 2020; 105(4). https://doi.org/10.1210/clinem/dgz117 PMID: 31665330
25.
Alansari LM, Wardle P. Endometrial polyps and subfertility. Hum Fertil (Camb). 2012; 15(3):129–33.
https://doi.org/10.3109/14647273.2012.711499 PMID: 22783910
26.
Busnelli A, Paffoni A, Fedele L, Somigliana E. The impact of thyroid autoimmunity on IVF/ICSI outcome:
a systematic review and meta-analysis. Hum Reprod Update. 2016; 22(6):793–4. https://doi.org/10.
1093/humupd/dmw034 PMID: 27671830
27.
Chan YY, Jayaprakasan K, Tan A, Thornton JG, Coomarasamy A, Raine-Fenning NJ. Reproductive
outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol. 2011; 38(4):371–82. https://doi.org/10.1002/uog.10056 PMID: 21830244
28.
Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol. 2008; 198(4):357–66. https://doi.org/
10.1016/j.ajog.2007.12.039 PMID: 18395031
29.
Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF
outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF.
Hum Reprod. 1999; 14(11):2762–9. https://doi.org/10.1093/humrep/14.11.2762 PMID: 10548619
30.
Barratt CLR, Bjorndahl L, De Jonge CJ, Lamb DJ, Osorio Martini F, McLachlan R, et al. The diagnosis
of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities. Hum Reprod Update. 2017; 23(6):660–80. https://doi.org/10.
1093/humupd/dmx021 PMID: 28981651
31.
Practice Committee of the American Society for Reproductive M. Diagnostic evaluation of the infertile
female: a committee opinion. Fertil Steril. 2015; 103(6):e44–50. https://doi.org/10.1016/j.fertnstert.
2015.03.019 PMID: 25936238
32.
Agarwal A, Baskaran S, Parekh N, Cho CL, Henkel R, Vij S, et al. Male infertility. Lancet. 2021; 397
(10271):319–33. https://doi.org/10.1016/S0140-6736(20)32667-2 PMID: 33308486
33.
Farquhar CM, Bhattacharya S, Repping S, Mastenbroek S, Kamath MS, Marjoribanks J, et al. Female
subfertility. Nat Rev Dis Primers. 2019; 5(1):7. https://doi.org/10.1038/s41572-018-0058-8 PMID:
30679436
34.
Deroux A, Dumestre-Perard C, Dunand-Faure C, Bouillet L, Hoffmann P. Female Infertility and Serum
Auto-antibodies: a Systematic Review. Clin Rev Allergy Immunol. 2017; 53(1):78–86. https://doi.org/10.
1007/s12016-016-8586-z PMID: 27628237
35.
Kahyaoglu I, Demir B, Turkkani A, Cinar O, Dilbaz S, Dilbaz B, et al. Total fertilization failure: is it the
end of the story? J Assist Reprod Genet. 2014; 31(9):1155–60. https://doi.org/10.1007/s10815-0140281-5 PMID: 24962788
36.
Quaas A, Dokras A. Diagnosis and treatment of unexplained infertility. Rev Obstet Gynecol. 2008; 1
(2):69–76. PMID: 18769664
37.
Edwards RG. Human implantation: the last barrier in assisted reproduction technologies? Reprod
Biomed Online. 2007; 14 Spec No 1:5–22. https://doi.org/10.1016/S1472-6483(10)61454-X PMID:
20483395
PLOS ONE | https://doi.org/10.1371/journal.pone.0249775 April 7, 2021
12 / 14
PLOS ONE
EMT in CE endometrium
38.
Fitzgerald JS, Poehlmann TG, Schleussner E, Markert UR. Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3). Hum Reprod
Update. 2008; 14(4):335–44. https://doi.org/10.1093/humupd/dmn010 PMID: 18424427
39.
Kim SM, Kim JS. A Review of Mechanisms of Implantation. Dev Reprod. 2017; 21(4):351–9. https://doi.
org/10.12717/DR.2017.21.4.351 PMID: 29359200
40.
Owusu-Akyaw A, Krishnamoorthy K, Goldsmith LT, Morelli SS. The role of mesenchymal-epithelial
transition in endometrial function. Hum Reprod Update. 2019; 25(1):114–33. https://doi.org/10.1093/
humupd/dmy035 PMID: 30407544
41.
Yao Y, Chen R, Wang G, Zhang Y, Liu F. Exosomes derived from mesenchymal stem cells reverse
EMT via TGF-beta1/Smad pathway and promote repair of damaged endometrium. Stem Cell Res Ther.
2019; 10(1):225. https://doi.org/10.1186/s13287-019-1332-8 PMID: 31358049
42.
Wilson MR, Reske JJ, Holladay J, Wilber GE, Rhodes M, Koeman J, et al. ARID1A and PI3-kinase
pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion. Nat
Commun. 2019; 10(1):3554. https://doi.org/10.1038/s41467-019-11403-6 PMID: 31391455
43.
Moustafa S, Young SL. Diagnostic and therapeutic options in recurrent implantation failure. F1000Res.
2020; 9. https://doi.org/10.12688/f1000research.22403.1 PMID: 32266059
44.
Bashiri A, Halper KI, Orvieto R. Recurrent Implantation Failure-update overview on etiology, diagnosis,
treatment and future directions. Reprod Biol Endocrinol. 2018; 16(1):121. https://doi.org/10.1186/
s12958-018-0414-2 PMID: 30518389
45.
Zargar M, Ghafourian M, Nikbakht R, Mir Hosseini V, Moradi Choghakabodi P. Evaluating Chronic
Endometritis in Women with Recurrent Implantation Failure and Recurrent Pregnancy Loss by Hysteroscopy and Immunohistochemistry. J Minim Invasive Gynecol. 2020; 27(1):116–21. https://doi.org/10.
1016/j.jmig.2019.02.016 PMID: 30851430
46.
Buzzaccarini G, Vitagliano A, Andrisani A, Santarsiero CM, Cicinelli R, Nardelli C, et al. Chronic endometritis and altered embryo implantation: a unified pathophysiological theory from a literature systematic review. J Assist Reprod Genet. 2020; 37(12):2897–911. https://doi.org/10.1007/s10815-02001955-8 PMID: 33025403
47.
Chae YK, Chang S, Ko T, Anker J, Agte S, Iams W, et al. Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC). Sci Rep.
2018; 8(1):2918. https://doi.org/10.1038/s41598-018-21061-1 PMID: 29440769
48.
Gibbons DL, Creighton CJ. Pan-cancer survey of epithelial-mesenchymal transition markers across the
Cancer Genome Atlas. Dev Dyn. 2018; 247(3):555–64. https://doi.org/10.1002/dvdy.24485 PMID:
28073171
49.
Minke B, Vandamme D, Schwarzl T, Kolch W, Martin F. Next Generation RNA Sequencing Analysis
Reveals Expression of a Transient EMT Profile During Early Organization of MCF10A Cells in 3D. Methods Mol Biol. 2017; 1501:233–43. https://doi.org/10.1007/978-1-4939-6475-8_11 PMID: 27796956
50.
Bartley J, Julicher A, Hotz B, Mechsner S, Hotz H. Epithelial to mesenchymal transition (EMT) seems to
be regulated differently in endometriosis and the endometrium. Arch Gynecol Obstet. 2014; 289
(4):871–81. https://doi.org/10.1007/s00404-013-3040-4 PMID: 24170160
51.
Zhang J, Tian XJ, Xing J. Signal Transduction Pathways of EMT Induced by TGF-beta, SHH, and WNT
and Their Crosstalks. J Clin Med. 2016; 5(4).
52.
Ricciardi M, Zanotto M, Malpeli G, Bassi G, Perbellini O, Chilosi M, et al. Epithelial-to-mesenchymal
transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells. Br J Cancer. 2015; 112(6):1067–75. https://doi.org/10.1038/bjc.2015.
29 PMID: 25668006
53.
Tortorella C, Piazzolla G, Matteo M, Pinto V, Tinelli R, Sabba C, et al. Interleukin-6, interleukin-1beta,
and tumor necrosis factor alpha in menstrual effluents as biomarkers of chronic endometritis. Fertil
Steril. 2014; 101(1):242–7. https://doi.org/10.1016/j.fertnstert.2013.09.041 PMID: 24314919
54.
Ju J, Li L, Xie J, Wu Y, Wu X, Li W. Toll-like receptor-4 pathway is required for the pathogenesis of
human chronic endometritis. Exp Ther Med. 2014; 8(6):1896–900. https://doi.org/10.3892/etm.2014.
1990 PMID: 25371751
55.
Liu L, Yang H, Guo Y, Yang G, Chen Y. The impact of chronic endometritis on endometrial fibrosis and
reproductive prognosis in patients with moderate and severe intrauterine adhesions: a prospective
cohort study. Fertil Steril. 2019; 111(5):1002–10 e2. https://doi.org/10.1016/j.fertnstert.2019.01.006
PMID: 30922643
56.
Yu L, Mu Y, Sa N, Wang H, Xu W. Tumor necrosis factor alpha induces epithelial-mesenchymal transition and promotes metastasis via NF-kappaB signaling pathway-mediated TWIST expression in hypopharyngeal cancer. Oncol Rep. 2014; 31(1):321–7. https://doi.org/10.3892/or.2013.2841 PMID:
24220622
PLOS ONE | https://doi.org/10.1371/journal.pone.0249775 April 7, 2021
13 / 14
PLOS ONE
EMT in CE endometrium
57.
Wu Y, Zhou BP. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer. 2010; 102(4):639–44. https://doi.org/10.1038/sj.bjc.6605530 PMID: 20087353
58.
Zhang F, Wang H, Wang X, Jiang G, Liu H, Zhang G, et al. TGF-beta induces M2-like macrophage
polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget. 2016; 7
(32):52294–306. https://doi.org/10.18632/oncotarget.10561 PMID: 27418133
59.
Moon H, Ju HL, Chung SI, Cho KJ, Eun JW, Nam SW, et al. Transforming Growth Factor-beta Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail. Gastroenterology. 2017; 153(5):1378–91
e6. https://doi.org/10.1053/j.gastro.2017.07.014 PMID: 28734833
60.
Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, et al. EMT and dissemination precede
pancreatic tumor formation. Cell. 2012; 148(1–2):349–61. https://doi.org/10.1016/j.cell.2011.11.025
PMID: 22265420
61.
Kang SH, Kim SW, Kim KJ, Cho KH, Park JW, Kim CD, et al. Effects of tranilast on the epithelial-tomesenchymal transition in peritoneal mesothelial cells. Kidney Res Clin Pract. 2019; 38(4):472–80.
https://doi.org/10.23876/j.krcp.19.049 PMID: 31554027
62.
Harigai R, Sakai S, Nobusue H, Hirose C, Sampetrean O, Minami N, et al. Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient
cells. Sci Rep. 2018; 8(1):6069. https://doi.org/10.1038/s41598-018-24484-y PMID: 29666462
63.
Kitaya K, Yasuo T. Inter-observer and intra-observer variability in immunohistochemical detection of
endometrial stromal plasmacytes in chronic endometritis. Exp Ther Med. 2013; 5(2):485–8. https://doi.
org/10.3892/etm.2012.824 PMID: 23407614
64.
Lundberg FE, Iliadou AN, Rodriguez-Wallberg K, Gemzell-Danielsson K, Johansson ALV. The risk of
breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based
study. Eur J Epidemiol. 2019; 34(5):499–507. https://doi.org/10.1007/s10654-018-0474-9 PMID:
30623293
65.
Yang HP, Cook LS, Weiderpass E, Adami HO, Anderson KE, Cai H, et al. Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2).
Br J Cancer. 2015; 112(5):925–33. https://doi.org/10.1038/bjc.2015.24 PMID: 25688738
66.
de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management.
Lancet. 2010; 376(9742):730–8. https://doi.org/10.1016/S0140-6736(10)60490-4 PMID: 20801404
67.
Prescott J, Farland LV, Tobias DK, Gaskins AJ, Spiegelman D, Chavarro JE, et al. A prospective cohort
study of endometriosis and subsequent risk of infertility. Hum Reprod. 2016; 31(7):1475–82. https://doi.
org/10.1093/humrep/dew085 PMID: 27141041
68.
Lopez-Novoa JM, Nieto MA. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med. 2009; 1(6–7):303–14. https://doi.org/10.1002/emmm.200900043 PMID:
20049734
69.
Zhou C, Liu J, Tang Y, Liang X. Inflammation linking EMT and cancer stem cells. Oral Oncol. 2012; 48
(11):1068–75. https://doi.org/10.1016/j.oraloncology.2012.06.005 PMID: 22766510
70.
Proestling K, Birner P, Gamperl S, Nirtl N, Marton E, Yerlikaya G, et al. Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis. Reprod Biol Endocrinol. 2015; 13:75. https://doi.org/10.1186/s12958-015-0063-7 PMID:
26198055
71.
Denisov EV, Perelmuter VM. A fixed partial epithelial-mesenchymal transition (EMT) triggers carcinogenesis, whereas asymmetrical division of hybrid EMT cells drives cancer progression. Hepatology.
2018; 68(3):807–10. https://doi.org/10.1002/hep.29784 PMID: 29331068
72.
Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war
on cancer. Oncogene. 2010; 29(34):4741–51. https://doi.org/10.1038/onc.2010.215 PMID: 20531305
73.
Chen T, You Y, Jiang H, Wang ZZ. Epithelial-mesenchymal transition (EMT): A biological process in the
development, stem cell differentiation, and tumorigenesis. J Cell Physiol. 2017; 232(12):3261–72.
https://doi.org/10.1002/jcp.25797 PMID: 28079253
PLOS ONE | https://doi.org/10.1371/journal.pone.0249775 April 7, 2021
14 / 14
...